Oxidative stress implication in a new phenotype of amyotrophic quadricipital syndrome with cardiac involvement due to lamin A/C mutation

References

• Kontush A. Amyloid-β: An antioxidant that becomes a pro-oxidant and critically contributes to Alzheimer's disease. Free Radic Biol Med 2001; 31: 1120–1131
   PubMed Web of Science ®Google Scholar
• Dexter DT, Carter CJ, Wells FR, Javoy-Agid Y, Lees AJ, Jenner P, Marsden CD. Basal lipid peroxidation in substantia nigra is increased in Parkinson's disease. J Neurochem 1998; 52: 381–389
   Google Scholar
• Dexter DT, Wells FR, Lees AJ, Agid F, Agid Y, Jenner P, Marsden CD. Increased nigral iron content and alterations in other metal ions occuring in brain in Parkinson's disease. J Neurochem 1989; 52: 1830–1836
   PubMed Web of Science ®Google Scholar
• Schapira AHV, Cooper JM, Dexter D, Clark JP, Jenner P, Marsden CD. Mitochondrial complex I deficiency in Parkinson's disease. J Neurochem 1990; 52: 823–827
   Google Scholar
• Bolli R, Jeroudi M, Patel B, Aruoma O, Halliwell B, Lai E, McCay P. Marked reduction of free radical generation and contractile dysfunction by antioxidant therapy begun at the time of reperfusion. Evidence that myocardial “stunning” is a manifestation of reperfusion injury. Circ Res 1989; 65: 607–622
   PubMed Web of Science ®Google Scholar
• Date MO, Morita T, Yamashita N, Nishida K, Yamaguchi O, Higuchi Y, Hirotani S, Matsumura Y, Hori M, Tada M, Otsu K. The antioxidant N-2-mercaptopropionyl glycine attenuates left ventricular hypertrophy in in vivo murine pressure-overload model. J Am Coll Cardiol 2002; 39: 907–912
   PubMed Web of Science ®Google Scholar
• Vassalle C, Petrozzi L, Botto N, Andreassi MG, Zucchelli GC. Oxidative stress and its association with coronary artery disease and different atherogenic risk factors. J Intern Med 2004; 256: 308–315
   PubMed Web of Science ®Google Scholar
• Remondino A, Kwon SH, Communal C, Pimentel DR, Sawyer DB, Singh K, Colucci WS. Beta-adrenergic receptor-stimulated apoptisis in cardiac myocytes is mediated by reactive oxygen species/c-Jun NH2-terminal kinase-dependant activation of the mitochondrial pathway. Circ Res 2003; 92: 136–138
   PubMed Web of Science ®Google Scholar
• Sawyer DB, Siwik DA, Xiao L, Pimentel DR, Singh K, Colucci WS. Role of oxidative stress in myocardial hypertrophy and failure. J Mol Cell Cardiol 2002; 34: 379–388
   PubMed Web of Science ®Google Scholar
• Askanas V, Engel K. Newest approaches to diagnosis and pathogenesis of sporadic inclusion-body myositis and hereditary inclusion-body myopathies, including molecular-pathologic similarities to Alzheimer disease. Inclusion-body myositis and myopathies, V Askanas, G Serratrice, WK Engel. Cambridge University Press. 1998; 3–78
   Google Scholar
• Charniot JC, Desnos M, Zerhouni K, Bonnefont-Rousselot D, Albertini JP, Salama JZ, Bassez G, Komajda M, Artigou JY. Severe dilated cardiomyopathy and quadriceps myopathy due to lamin A/C gene mutation: A phenotypic study. Eur J Heart Fail 2006; 8: 249–256
   PubMed Web of Science ®Google Scholar
• Charniot JC, Pascal C, Bouchier C, Sébillon P, Salama J, Duboscq-Bidot L, Peuchmaurd M, Desnos M, Artigou JY, Komajda M. Functional consequences of an LMNA mutation associated with a new cardiac and non-cardiac phenotype. Hum Mutat 2003; 21: 473–481
   PubMed Web of Science ®Google Scholar
• Brodsky GL, Muntoni F, Miocic S, Sinagra G, Sewry C, Mestroni L. Lamin A/C gene mutation associated with dilated cardiomyopathy with variable skeletal muscle involvement. Circulation 2000; 101: 473–476
   PubMed Web of Science ®Google Scholar
• Van Der Kooi AJ, Ledderhof TM, de Voogt WG, Res CJ, Bouwsma G, Troost D, Busch HF, Becker AE, de Visser M. A newly recognized autosomal dominant limb girdle muscular dystrophy with cardiac involvement. Ann Neurol 1996; 39: 636–642
   PubMed Web of Science ®Google Scholar
• Allain CC, Poon LS, Chan C, Richmond SG, Fu PC. Enzymatic determination of total serum cholesterol. Clin Chem 1974; 20: 470–475
   PubMed Web of Science ®Google Scholar
• Eggstein M, Kreutz FH. Eine neue bestimmung der neutrafette im blutserum und gewebe. Klin Wochenschr 1966; 44: 262–267
   PubMedGoogle Scholar
• Takayama M, Itoh S, Nagasaki T, Tanimipu J. A new enzymatic method for determination of serum choline-containing phospholipids. Clin Chim Acta 1977; 79: 93–98
   PubMed Web of Science ®Google Scholar
• Sugiuchi H, Uji Y, Okabe H, Irie T, Uekama K, Kayahara N, Miyauchi K. Direct measurement of high-density lipoprotein cholesterol in serum with polyethylene glycol-modified enzymes and sulfated alpha-cyclodextrin. Clin Chem 1995; 41: 717–723
   PubMed Web of Science ®Google Scholar
• Bonnefont-Rousselot D, Jaudon MC, Issad B, Cacoub P, Congy F, Jardel C, Delattre J, Jacobs C. Antioxidant status of elderly chronic renal patients treated by continuous ambulatory peritoneal dialysis. Nephrol Dial Transpl 1997; 12: 1399–1405
   PubMed Web of Science ®Google Scholar
• Yagi K. A simple fluorometric assay for lipoperoxide in blood plasma. Biochem Med 1976; 15: 212–216
   PubMed Web of Science ®Google Scholar
• Wang Z, Ciabattoni G, Créminon C, Lawson J, Fitzgerald GA, Patrono C, Maclouf J. Immunological characterization of urinary 8-epi-prostaglandin F2α excretion in man. J Pharmacol Exp Ther 1995; 275: 94–100
   PubMed Web of Science ®Google Scholar
• Levine RL, Garland D, Oliver N, Amici A, Liment I, Lenz AG, Ahn B, Shaltiel S, Stadtman ER. Determination of carbonyl content in oxidatively modified proteins. Methods Enzymol 1990; 186: 464–478
   PubMed Web of Science ®Google Scholar
• Arnaud J, Fortis I, Blachier S, Kia D, Favier A. Simultaneous determination of retinol, α-tocopherol and β-carotene in serum by isocratic high performance liquid chromatography. J Chromatogr 1991; 572: 103–116
   PubMed Web of Science ®Google Scholar
• Miller NJ, Rice-Evans CA, Davies MJ, Gopinathan V, Milner A. A novel method for measuring antioxidant capacity and its application to monitoring the antioxidant status in premature neonates. Clin Sci 1993; 84: 407–412
   PubMed Web of Science ®Google Scholar
• Bredt DS, Snyder SH. Nitric oxide mediates glutamate-linked enhancement of cGMP levels in the cerebellum. Proc Natl Acad Sci 1989; 86: 9030–9033
   PubMed Web of Science ®Google Scholar
• Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein dye binding. Anal Biochem 1976; 72: 248–254
   PubMed Web of Science ®Google Scholar
• Marston SB, Hodgkinson JL. Cardiac and skeletal myopathies: Can genotype explain phenotype?. J Muscle Res Cell Motil 2001; 22: 1–4
   PubMedGoogle Scholar
• Sunohara N, Arahata K, Hoffman EP, Yamada H, Nishimiya J, Arikawa E, Kaido M, Nonaka I, Sugita H. Quadriceps myopathy: Forme fruste of Becker muscular dystrophy. Ann Neurol 1990; 28: 634–639
   PubMedGoogle Scholar
• Lotz BP, Engel AG, Nishino H, Stevens JC, Litchy WJ. Inclusion body myositis: Observations of 40 patients. Brain 1989; 112: 727–747
   PubMed Web of Science ®Google Scholar
• McMurray J, Chopra M, Abdullah K, Smith W, Dargie H. Evidence of oxidative stress in chronic heart failure in humans. Eur Heart J 1993; 14: 1493–1498
   PubMed Web of Science ®Google Scholar
• Singh RB, Niaz MA, Rastagi SS, Rastagi S. Usefulness of antioxidant vitamins in suspected acute myocardial infarctions (the Indian experiment of infarct survival-3). Am J Cardiol 1996; 77: 232–236
   PubMed Web of Science ®Google Scholar
• Singal PK, Khaper N, Palace V, Kumar D. The role of oxidative stress in the genesis of heart disease. Cardiovasc Res 1998; 40: 426–432
   PubMed Web of Science ®Google Scholar
• Cracowski JL, Tremel F, Marpeau C, Baguet JP, Stanke-Labesque F, Mallion JM, Bessard G. Increased formation of F(2) -isoprostanes in patients with severe heart failure. Heart 2000; 84: 439–440
   PubMed Web of Science ®Google Scholar
• Lawson JA, Rokach J, Fitzgerald GA. Isoprostanes: Formation, analysis and use as indices of lipid peroxidation in vivo. J Biol Chem 1999; 274: 24441–24444
   PubMed Web of Science ®Google Scholar
• Cesselli D, Jakoniuk I, Barlucchi L, Beltrami AP, Hintze TH, Nadal-Ginard B, Kajstura J, Leri A, Anversa P. Oxidative stress-mediated cardiac cell death is a major determinant of ventricular dysfunction and failure in dog dilated cardiomyopathy. Circ Res 2001; 89: 279–286
   PubMed Web of Science ®Google Scholar
• Bonne G, Di Barletta MR, Varnous S, Becane HM, Hammouda EH, Merlini L, Muntoni F, Greenberg CR, Gary F, Urtizberea JA, Duboc D, Fardeau M, Toniolo D, Schwartz K. Mutations in the gene encoding lamin A/C cause autosomal dominant emery-dreifuss muscular dystrophy. Nat Genet 1999; 21: 285–288
   PubMed Web of Science ®Google Scholar
• Eaton Ph, Jones ME, McGregor E, Dunn MJ, Leeds N, Byers HL, Leung KY, Ward MA, Pratt JR, Shattock MJ. Reversible cysteine-targeted oxidation of proteins during renal oxidative stress. J Am Soc Nephrol 2003; 14: S290–S296
   Google Scholar
• Byrne JA, Grieve DJ, Cave AC, Shah AM. Oxidative stress and heart failure. Arch Mal Cœur Vaiss 2003; 96: 214–221
   Google Scholar
• Davies KJA, Delsignore ME. Protein damage and degradation by oxygen radicals: Modification of secondary and tertiary structure. J Biol Chem 1987; 262: 9908–9913
   PubMed Web of Science ®Google Scholar
• Conrad CC, Marshall PL, Talent JM, Malakowsky CA, Choi J, Gracy RW. Oxidized proteins in Alzheimer's plasma. Biochem Biophys Res Commun 2002; 275: 678–681
   Google Scholar
• Del Rio D, Stewart AJ, Pellegrini N. A review of recent studies on malondialdehyde as toxic molecule and biological marker of oxidative stress. Nutr Metab Cardiovasc Dis 2005; 15: 316–328
   PubMed Web of Science ®Google Scholar
• Baynes JW. Perspectives in diabetes. Role of oxidative stress in development of complications in diabetes. Diabetes 1996; 40: 405–411
   Google Scholar
• Pantke U, Volk T, Schmutzler M, Kox WJ, Sitte N, Grune T. Oxidized proteins as a marker of oxidative stress during coronary heart surgery. Free Radic Biol Med 1999; 27: 1080–1086
   PubMed Web of Science ®Google Scholar
• Dalle-Donne I, Giustarini D, Colombo R, Rossi R, Milzani A. Protein carbonylation in human diseases. Trends Mol Med 2003; 9: 169–176
   PubMed Web of Science ®Google Scholar
• Torelli S, Brown SC, Jimenez-Mallebrera C, Feng L, Muntoni F, Sewry CA. Absence of neuronal oxide synthase (nNOS) as a pathological marker for the diagnosis of Becker muscular dystrophy with rod domain deletions. Neuropathol Appl Neurobiol 2004; 30: 540–545
   PubMedGoogle Scholar
• Drexler H, Kastner S, Strobel A, Struder R, Brodde OE, Hasenfrub G. Expression, activity and functional significance of inductible nitric oxide synthase in the failing human heart. J Am Coll Cardiol 1998; 32: 955–963
   PubMedGoogle Scholar
• Vejlstrup NG, Bouloumie A, Boesgaard S, Andersen CB, Nielsen-Kudsk JE, Mortensen SA, Kent JD, Harrison DG, Busse R, Aldershvile J. Inductible nitric oxide synthase (iNOS) in the human heart: Expression and localization in congestive heart failure. J Mol Cell Cardiol 1998; 30: 1215–1223
   PubMed Web of Science ®Google Scholar
• Damy T, Ratajczak P, Shah AM, Camors E, Marty I, Hasenfuss G, Marotte F, Samuel JL, Heymes C. Increased neuronal nitric oxide synthase-derived NO production in the failing human heart. Lancet 2004; 363: 1365–1367
   PubMedGoogle Scholar
• Bendall JK, Damy T, Ratajczak P, Loyer X, Monceau V, Marty I, Milliez P, Robidel E, Marotte F, Samuel JL, Heymes C. Role of myocardial neuronal nitric oxide synthase-derived nitric oxide in beta-adrenergic hyporesponsiveness after myocardial infarction-induced heart failure in rat. Circulation 2004; 110: 2368–2375
   PubMedGoogle Scholar